{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:30:17Z","timestamp":1786501817941,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","award":["QN202234"],"award-info":[{"award-number":["QN202234"]}],"id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","award":["CMCC202201"],"award-info":[{"award-number":["CMCC202201"]}],"id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.prp.2026.156526","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:12:49Z","timestamp":1778548369000},"page":"156526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CBLC inhibits ferroptosis of gastric cancer cells by inducing K48-linked polyubiquitination and degradation of SH2D4A"],"prefix":"10.1016","volume":"286","author":[{"given":"Jingjing","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2026.156526_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17305\/bb.2024.10887","article-title":"Exploring the therapeutic potential of diterpenes in gastric cancer: Mechanisms, efficacy, and clinical prospects","volume":"25","author":"Ma","year":"2025","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.prp.2026.156526_bib2","article-title":"Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis","volume":"15","author":"Lu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"23","key":"10.1016\/j.prp.2026.156526_bib3","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1111\/jcmm.17967","article-title":"Exploring the mechanism of ellagic acid against gastric cancer based on bioinformatics analysis and network pharmacology","volume":"27","author":"Liu","year":"2023","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156526_bib4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s12672-024-01641-6","article-title":"Network pharmacology and anticancer mechanism study of Dendrobium nobile dendrobine in the treatment of colorectal cancer","volume":"15","author":"Luo","year":"2024","journal-title":"Discov. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2026.156526_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41418-024-01263-z","article-title":"FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism","volume":"31","author":"Miao","year":"2024","journal-title":"Cell Death & Differ."},{"issue":"1","key":"10.1016\/j.prp.2026.156526_bib6","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1038\/s41467-024-53380-5","article-title":"Methionine-SAM metabolism-dependent ubiquinone synthesis is crucial for ROS accumulation in ferroptosis induction","volume":"15","author":"Xia","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.prp.2026.156526_bib7","first-page":"230","article-title":"Suppression of USP8 sensitizes cells to ferroptosis via SQSTM1\/p62-mediated ferritinophagy","volume":"14","author":"Liu","year":"2023","journal-title":"Protein & Cell"},{"key":"10.1016\/j.prp.2026.156526_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1506492","article-title":"The impact of ferroptosis and ferroptosis-related non-coding RNAs on breast cancer progression","volume":"12","author":"Liu","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2026.156526_bib9","doi-asserted-by":"crossref","first-page":"rbad004","DOI":"10.1093\/rb\/rbad004","article-title":"Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy","volume":"10","author":"Liu","year":"2023","journal-title":"Regen. Biomater."},{"issue":"1","key":"10.1016\/j.prp.2026.156526_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12672-025-02151-9","article-title":"WGCNA and ferroptosis genes in OSCC: unraveling prognostic biomarkers and therapeutic targets","volume":"16","author":"Liu","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156526_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13402-023-00858-x","article-title":"Ferritinophagy induced ferroptosis in the management of cancer","volume":"47","author":"Liu","year":"2024","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.prp.2026.156526_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43556-021-00043-2","article-title":"E3 ubiquitin ligases: styles, structures and functions","volume":"2","author":"Yang","year":"2021","journal-title":"Mol. Biomed."},{"issue":"6","key":"10.1016\/j.prp.2026.156526_bib13","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202503243","article-title":"The RBR E3 ubiquitin ligase HOIL-1 can ubiquitinate diverse non-protein substrates in vitro","volume":"8","author":"Wang","year":"2025","journal-title":"Life Sci. Alliance"},{"issue":"4","key":"10.1016\/j.prp.2026.156526_bib14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/eji.201646484","article-title":"Negative regulators of the RIG-I-like receptor signaling pathway","volume":"47","author":"Quicke","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"24","key":"10.1016\/j.prp.2026.156526_bib15","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1182\/bloodadvances.2021005736","article-title":"KMT2A-CBL rearrangements in acute leukemias: clinical characteristics and genetic breakpoints","volume":"5","author":"Bataller","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.prp.2026.156526_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-1119(03)00471-2","article-title":"Comparative genomic organization of the cbl genes","volume":"308","author":"Nau","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.prp.2026.156526_bib17","first-page":"1","article-title":"RNA-binding protein SOX2 promotes distal metastasis and cisplatin resistance in non-small cell lung cancer by stabilizing CBLC","author":"Zhuo","year":"2025","journal-title":"Mol. & Cell. Toxicol."},{"key":"10.1016\/j.prp.2026.156526_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101992","article-title":"CBLC promotes the development of colorectal cancer by promoting ABI1 degradation to activate the ERK signaling pathway","volume":"45","author":"Li","year":"2024","journal-title":"Transl. Oncol."},{"issue":"17","key":"10.1016\/j.prp.2026.156526_bib19","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1158\/0008-5472.CAN-17-3858","article-title":"Upregulation of E3 ubiquitin ligase CBLC enhances EGFR dysregulation and signaling in lung adenocarcinoma","volume":"78","author":"Hong","year":"2018","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2026.156526_bib20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1080\/10799893.2022.2116049","article-title":"CBLC inhibits the proliferation and metastasis of breast cancer cells via ubiquitination and degradation of CTTN","volume":"42","author":"Li","year":"2022","journal-title":"J. Recept. Signal Transduct."},{"issue":"0","key":"10.1016\/j.prp.2026.156526_bib21","article-title":"Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p\/SLC7A11 Signaling","volume":"21","author":"Yan Ze","year":"2022","journal-title":"Technol. Cancer Res Treat."},{"issue":"1","key":"10.1016\/j.prp.2026.156526_bib22","article-title":"Sodium pyruvate exerts protective effects against cigarette smoke extract-induced ferroptosis in alveolar and bronchial epithelial cells through the GPX4\/Nrf2 axis","volume":"20","author":"Ziwen","year":"2023","journal-title":"J. Inflamm. (Lond. )"},{"issue":"0","key":"10.1016\/j.prp.2026.156526_bib23","article-title":"5-Oxoproline prevents doxorubicin-induced cardiotoxicity and tumor growth","volume":"85","author":"Xinning","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.prp.2026.156526_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110997","article-title":"SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK\/PI3K\/AKT signaling pathway","volume":"114","author":"Shi","year":"2024","journal-title":"Cell Signal"},{"issue":"7","key":"10.1016\/j.prp.2026.156526_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70551","article-title":"USP13 Facilitates the Proliferation of Hepatocellular Carcinoma Cells by Reducing K48\/63-Linked Polyubiquitination and Degradation of PRPF6","volume":"29","author":"Jiang","year":"2025","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156526_bib26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3892\/ol.2023.13872","article-title":"The \u2018double\u2011track sign\u2019: A novel CT finding suggestive of the diagnosis of T1a gastric cancer","volume":"26","author":"Liang","year":"2023","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.prp.2026.156526_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.104482","article-title":"Integrated clinico-molecular analysis of gastric cancer in European and Latin American populations: LEGACY project","volume":"10","author":"Dienstmann","year":"2025","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.prp.2026.156526_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/cas.14224","article-title":"Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy","volume":"111","author":"Otsuki","year":"2020","journal-title":"Cancer Sci."},{"issue":"22","key":"10.1016\/j.prp.2026.156526_bib29","doi-asserted-by":"crossref","first-page":"16339","DOI":"10.3390\/ijms242216339","article-title":"FTO sensitizes oral squamous cell carcinoma to ferroptosis via suppressing ACSL3 and GPX4","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.prp.2026.156526_bib30","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1007\/s10571-023-01388-8","article-title":"The mechanisms of ferroptosis under hypoxia","volume":"43","author":"Gao","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.prp.2026.156526_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101154","article-title":"E3 ubiquitin ligase DTX2 fosters ferroptosis resistance via suppressing NCOA4-mediated ferritinophagy in non-small cell lung cancer","volume":"77","author":"Liu","year":"2024","journal-title":"Drug Resist. Updates"},{"issue":"2","key":"10.1016\/j.prp.2026.156526_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","article-title":"CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1","volume":"42","author":"Li","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2026.156526_bib33","first-page":"1","article-title":"USP38 functions as an oncoprotein by downregulating the p53 pathway through deubiquitination and stabilization of MDM2","author":"Zhao","year":"2025","journal-title":"Cell Death & Differ."},{"issue":"1","key":"10.1016\/j.prp.2026.156526_bib34","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1038\/s41467-023-39901-8","article-title":"ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis","volume":"14","author":"Yang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2026.156526_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101992","article-title":"CBLC promotes the development of colorectal cancer by promoting ABI1 degradation to activate the ERK signaling pathway","volume":"45","author":"Li","year":"2024","journal-title":"Transl. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2026.156526_bib36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1080\/10799893.2022.2116049","article-title":"CBLC inhibits the proliferation and metastasis of breast cancer cells via ubiquitination and degradation of CTTN","volume":"42","author":"Li","year":"2022","journal-title":"J. Recept Signal Transduct. Res"},{"issue":"13","key":"10.1016\/j.prp.2026.156526_bib37","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/s41388-022-02180-6","article-title":"Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma","volume":"41","author":"Hong","year":"2022","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.prp.2026.156526_bib38","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1158\/0008-5472.CAN-17-3858","article-title":"Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma","volume":"78","author":"Hong","year":"2018","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.prp.2026.156526_bib39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41419-020-03220-3","article-title":"Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondria","volume":"11","author":"Ploeger","year":"2020","journal-title":"Cell death & Dis."},{"issue":"10","key":"10.1016\/j.prp.2026.156526_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41388-024-03235-6","article-title":"BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity","volume":"44","author":"Li","year":"2025","journal-title":"Oncogene"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:26:19Z","timestamp":1786501579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"alternative-id":["S0344033826001792"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156526","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CBLC inhibits ferroptosis of gastric cancer cells by inducing K48-linked polyubiquitination and degradation of SH2D4A","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156526"}}